CDC: More Chemical Exposures Reported in January to March 2020
Increases of 20.4 and 16.4 percent from January to March 2019 and January to March 2018
Chronic Conditions, Obesity Common in Fatal Cases of EVALI
More fatal and nonfatal cases were male and non-Hispanic white versus other race, ethnic groups
Lopinavir/Ritonavir, Umifenovir Ineffective for Mild COVID-19
Rate of positive-to-negative conversion of SARS-CoV-2 did not differ for drug therapy versus standard care
AAD Establishes Registry for Skin Manifestations of COVID-19
Initial study describes cutaneous involvement, which was reported in 20.4 percent of 88 patients
Scoring System Helps Guide Surgical Care During COVID-19
Twenty-one factors that were significant contributors to procedure triage and prioritization identified
Premature Mortality Rates Up for CAD in Women From Rural U.S.
And, rural social determinants of health increase risk for 90-day mortality after heart failure hospitalization
ST-Segment Elevation Described in Patients With COVID-19
Presentation variable with high prevalence of nonobstructive disease, poor prognosis
Expert Panel: There Are No Proven Drug Treatments for COVID-19
Whenever possible, drugs should be given to COVID-19 patients as part of a clinical trial
Rapid COVID-19 Test Can Produce False Negatives
Solutions known as 'viral transport media' should not be used for samples tested with the Abbott ID NOW device
Firework-Related ED Visits Peak Around Independence Day
Firecrackers, bottle rockets cause most injuries
